Nevertheless, although myostatin was not correlated with bone turnover markers, we cannot exclude the possibility that it contributed to the reduced bone formation, particularly in the women with class III obesity who presented concomitantly higher myostatin and lower osteocalcin levels. The gene discussed is MSTN; the disease is obesity due to melanocortin 4 receptor deficiency.